Early research (Phase 1)Looking for participantsNCT07225816
What this trial is testing
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Who this might be right for
Obesity
Novo Nordisk A/S 71